Institution statistics

BAYER AKTIENGESELLSCHAFT - Germany 

This institution has been merged with: BAYER.

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:200-300
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 16
As coordinator: 0
As participant: 16
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 134.956.838 529.687 10
2017 0 48.609.803 0 5
2015 0 4.090.249 249.216 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA8
JANSSEN PHARMACEUTICA NV7
PFIZER LIMITED7
UCB BIOPHARMA7
ELI LILLY AND COMPANY LIMITED6
F HOFFMANNLA ROCHE6
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER6
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT6
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
ASTRAZENECA AB4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
FUNDACIO SANT JOAN DE DEU3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
SANOFIAVENTIS DEUTSCHLAND3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY COLLEGE LONDON3
ABBVIE INC2
AMGEN LIMITED2
CELGENE MANAGEMENT SARL2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN PATIENTS' FORUM2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
GRUNENTHAL2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
MERCK SHARP & DOHME CORP2
NOVO NORDISK2
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN2
STICHTING KATHOLIEKE UNIVERSITEIT2
TARTU ULIKOOL2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY2
THE HYVE BV2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITAT WIEN2
UNIVERSITEIT LEIDEN2
UNIVERSITY OF BIRMINGHAM2
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV2
VIFOR2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGENZIA ITALIANA DEL FARMACO1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1
ALEXION SERVICES EUROPE SPRL1
ALFA LAVAL COPENHAGEN1
ALLEANZA CONTRO IL CANCRO1
ALZHEIMER EUROPE1
AMGEN1
ANZAC HEALTH & MEDICAL RESEARCH FOUNDATION1
ARISTOTLE UNIVERSITY THESSALONIKI1
ARSENALIT CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE1
ART PHOTONICS1
ARVALIS INSTITUT DU VEGETAL1
ASAR SOCIETA SEMPLICE AGRICOLA RANDAZZO1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA1
ASTELLAS PHARMA EUROPE BV1
AXXAM1
AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE1
AZIENDA SANITARIA UNIVERSITARIA INTEGRATA DI UDINE1
BAYER TECHNOLOGY SERVICES1
BIOASCENT DISCOVERY LIMITED1
CARL ZEISS MEDITEC1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CERTARA UK LIMITED1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY1
CHERRY BIOTECH1
CITY UNIVERSITY OF LONDON1
CLARIVATE ANALYTICS LIMITED1
COVANCE LABORATORIES1
DANMARKS TEKNISKE UNIVERSITET1
ECNP RESEARCH AND SCHOLARSHIP STICHTING1
EDELRIS SAS1
EIDGENOESSISCHES DEPARTEMENT FUER WIRTSCHAFT BILDUNG UND FORSCHUNG1
EISAI CO1
ELVESYS SAS1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN CYSTIC FIBROSIS SOCIETY1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN HEART NETWORK AISBL1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLINBUCH1
FOLKEHELSEINSTITUTTET1
FONDATION DE COOPERATION SCIENTIFIQUE VOIR ET ENTENDRE1
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS1
FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
GOETEBORGS UNIVERSITET1
Constancy:

Total number of partners:335

Partner loyalty:
Frequent Partner: (> 2 projects): 98
Rare Partner: 237

Frequent / Rare Partner Ratio: 0.41

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01RustWatch: A European early-warning system for wheat rust diseases RUSTWATCHparticipant4.999.99925
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells DeLIVERparticipant3.728.51314
2017-09-01Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 MACUSTARparticipant8.025.00013
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-03-01Big Data 4 Better Hearts - Sofia ref.: 116074 BigData Heartparticipant9.664.97019
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2015-11-01Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries ModLifeparticipant4.090.24912
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum